Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfatase

Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfatase

US Patent 12121567 · Granted Oct 22, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Analgesic and anti-addictive compositions for treatment of chronic pain and opio2024
Injection of single-stranded or self-complementary adeno-associated virus 9 into2024
AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy2023
Modified cells and methods of therapy2023
Combination for treating pain2022
Methods and compositions for treating glioma and medulloblastoma brain tumors us2022
Modified cells and methods of therapy2021
Method to achieve extended expression of DNA infused into liver2021
Methods and compositions for treating glioma and medulloblastoma brain tumors us2020
Magnetic nanostimulator and nanosensor array for biological material stimulation2019
Intracellular genomic transplant and methods of therapy2019
Deuterated bile acids2018